![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 14, 11049-11054, April 6, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Vaccination with heat shock protein
gp96-antigenic peptide complexes produces a powerful specific
immune response against cancers and infectious diseases in some
experimental animal models, and gp96-peptide complexes are now being
tested in human clinical trials. gp96 appears to serve as a natural
adjuvant for chaperoning antigenic peptides into the immune
surveillance pathways. A fundamental issue that needs to be addressed
is the mechanism of binding of antigenic peptide to gp96. Here, we show
using scanning transmission electron microscopy that recombinant gp96
binds peptide in stable multimeric complexes, which may have biological
significance. To open the possibility for genetically engineering gp96
for improved immunogenicity and to understand if molecular recognition
plays a role in the binding of antigenic peptide, we mutagenized some specific aromatic amino acids in the presumed peptide-binding pocket.
Replacement of Tyr-667 or Tyr-678 to Ala reduced affinity for
peptide whereas conversion of Trp-654 to Tyr increased peptide binding.
Similarly, changing Trp-621 to Phe or Leu or Ala or Ile negatively
affected peptide binding whereas changing Trp-621 to Tyr or Val
positively affected peptide binding. Probing the peptide microenvironment in gp96-peptide complexes, suggested that hydrophobic interactions (and perhaps hydrogen bonding/stacking
interactions) may play a role in peptide loading by gp96.
Binding of Antigenic Peptide to the Endoplasmic
Reticulum-resident Protein gp96/GRP94 Heat Shock Chaperone Occurs in
Higher Order Complexes
ESSENTIAL ROLE OF SOME AROMATIC AMINO ACID RESIDUES IN THE
PEPTIDE-BINDING SITE*
,
¶
Laboratory of Molecular Genetics, The
Rockefeller University, New York, New York 10021 and the
§ Department of Biology, Brookhaven National Laboratory,
Upton, New York 11973
*
This work was supported in part by grants from the Cancer
Research Inst., NY, Antigenics L.L.C, NY, Hewlett Packard Foundation (to S. S.), and Grant P41-RR01777 from the National Institutes of
Health and the United States Department of Energy Office of Biological
and Environmental Research (to M. N. S. and J. F. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
C. Biswas, U. Sriram, B. Ciric, O. Ostrovsky, S. Gallucci, and Y. Argon The N-terminal fragment of GRP94 is sufficient for peptide presentation via professional antigen-presenting cells Int. Immunol., July 1, 2006; 18(7): 1147 - 1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Suriano, S. K. Ghosh, B. T. Ashok, A. Mittelman, Y. Chen, A. Banerjee, and R. K. Tiwari Differences in Glycosylation Patterns of Heat Shock Protein, gp96: Implications for Prostate Cancer Prevention Cancer Res., July 15, 2005; 65(14): 6466 - 6475. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Demine and P. Walden Testing the Role of gp96 as Peptide Chaperone in Antigen Processing J. Biol. Chem., May 6, 2005; 280(18): 17573 - 17578. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vogen, T. Gidalevitz, C. Biswas, B. B. Simen, E. Stein, F. Gulmen, and Y. Argon Radicicol-sensitive Peptide Binding to the N-terminal Portion of GRP94 J. Biol. Chem., October 18, 2002; 277(43): 40742 - 40750. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |